- Corporate Officers - G
- Gray Mary Ann
Insider Trading History of Gray Mary Ann
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gray Mary Ann since 2005.
This trader's CIK number is 1261974.
At the time of last reporting, Gray Mary Ann was the Director of Sarepta Therapeutics, Inc.. (stock ticker symbol SRPT).
Also see all insider trading activities at Sarepta Therapeutics, Inc..
Note that in the past
GRAY MARY ANN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Senomyx Inc (SNMX) by Gray Mary Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | SNMX | 10,000 | $10,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mabvax Therapeutics Holdings, Inc. (TELK) by Gray Mary Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | TELK | 5,000 | $77,925 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Gtc Biotherapeutics Inc (GTCB) by Gray Mary Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | GTCB | 10,000 | $8,800 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Sarepta Therapeutics, Inc. (SRPT) by Gray Mary Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | SRPT | 0 | $0 | 0 | $0 | 967 | $0 |
| 2020 | SRPT | 0 | $0 | 0 | $0 | 967 | $0 |
| 2019 | SRPT | 0 | $0 | 0 | $0 | 967 | $0 |
Yearly summary of insider trading at Acadia Pharmaceuticals Inc (ACAD) by Gray Mary Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | ACAD | 0 | $0 | 0 | $0 | 149,476 | $327,073 |
| 2015 | ACAD | 0 | $0 | 4,250 | $148,750 | 4,250 | $46,750 |
| 2014 | ACAD | 0 | $0 | 12,250 | $388,815 | 12,250 | $112,369 |
| 2013 | ACAD | 0 | $0 | 15,000 | $309,975 | 15,000 | $121,200 |
Yearly summary of insider trading at Dyax Corp (DYAX) by Gray Mary Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | DYAX | 0 | $0 | 0 | $0 | 222,440 | $1,606,684 |
Insider trading activities at 6 companies by Gray Mary Ann:
1. Senomyx Inc (SNMX)
2. Mabvax Therapeutics Holdings, Inc. (TELK)
3. Gtc Biotherapeutics Inc (GTCB)
4. Sarepta Therapeutics, Inc. (SRPT)
5. Acadia Pharmaceuticals Inc (ACAD)
6. Dyax Corp (DYAX)
Table 1. Insider trading of Senomyx Inc (SNMX) by Gray Mary Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-03-24 | SNMX | Buy | 10,000 | 1.00 | 10,000 |
Table 2. Insider trading of Mabvax Therapeutics Holdings, Inc. (TELK) by Gray Mary Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-03-16 | TELK | Buy | 5,000 | 15.59 | 77,925 |
Table 3. Insider trading of Gtc Biotherapeutics Inc (GTCB) by Gray Mary Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-12-17 | GTCB | Buy | 10,000 | .88 | 8,800 |
Table 4. Insider trading of Sarepta Therapeutics, Inc. (SRPT) by Gray Mary Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-10 | SRPT | Option Ex | 967 | .00 | 0 |
| 2020-12-10 | SRPT | Option Ex | 967 | .00 | 0 |
| 2019-12-10 | SRPT | Option Ex | 967 | .00 | 0 |
Table 5. Insider trading of Acadia Pharmaceuticals Inc (ACAD) by Gray Mary Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-06-07 | ACAD | Option Ex | 16,637 | 9.04 | 150,398 |
| 2016-04-07 | ACAD | Option Ex | 132,839 | 1.33 | 176,675 |
| 2015-01-13 | ACAD | Option Ex | 4,250 | 11.00 | 46,750 |
| 2015-01-13 | ACAD | Sale | 4,250 | 35.00 | 148,750 |
| 2014-12-15 | ACAD | Option Ex | 12,250 | 9.17 | 112,369 |
| 2014-12-15 | ACAD | Sale | 12,250 | 31.74 | 388,815 |
| 2013-08-26 | ACAD | Sale | 15,000 | 20.66 | 309,975 |
| 2013-08-26 | ACAD | Option Ex | 15,000 | 8.08 | 121,200 |
Table 6. Insider trading of Dyax Corp (DYAX) by Gray Mary Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-01-14 | DYAX | Option Ex | 222,440 | 7.22 | 1,606,684 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gray Mary Ann
(Director of Sarepta Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.